(Q31004239)

28 June 2017

title

Cross-talk between PKA and PKC in human fibroblasts: what are the pharmacotherapeutic implications? (English)

1 reference

28 June 2017

Manier DH

1

1 reference

28 June 2017

Shelton RC

series ordinal

2

1 reference

28 June 2017

Sulser F

series ordinal

3

1 reference

28 June 2017

publication date

1 August 2001

1 reference

Journal of Affective Disorders

28 June 2017

published in

1 reference

28 June 2017

volume

65

1 reference

28 June 2017

issue

3

1 reference

28 June 2017

page(s)

275-279

1 reference

Clinical efficacy of reboxetine: a comparative study with desipramine, with methodological considerations

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

Rationale for the development of noradrenaline reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

Distinct adenosine 3',5'-monophosphate and phorbol ester-responsive signal transduction pathways converge at the level of transcriptional activation by the interactions of DNA-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

Beta-adrenoceptor-linked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

Human fibroblasts as a relevant model to study signal transduction in affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

Pharmacological actions of the antidepressant venlafaxine beyond aminergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

cAMP-dependent protein kinase activity in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

Expression of the liver-enriched transcriptional activator protein DBP follows a stringent circadian rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900278-0

7 January 2021

10.1016/S0165-0327(00)00278-0

Identifiers

DOI

1 reference

28 June 2017

1 reference